New stock news | Ted Medicine's Hong Kong IPO prospectus invalid

Zhitong Finance and Economics APP learned that the Hong Kong IPO prospectus submitted by Tede Pharmaceutical (Zhejiang) Co., Ltd. (Tede Pharmaceutical) on December 6, 2024, expired on June 6, 2025, after 6 months. Morgan Stanley and Citic Securities were joint sponsors when the prospectus was submitted.